EACH PATIENT IS NOTABLE AND CAN BENEFIT FROM A PREDICTIVE PRECISION MEDICINE THAT WORKS FOR THEM
Notable is a clinical-stage precision therapeutics company developing a new class of oncology medicines:
Predictive Precision Medicines.
We address the question that matters most to the patient:
“Doctor, will this treatment work for me?”
Addressing this question is critical and urgent. Two decades into precision medicine, many cancer treatments still deliver only modest clinical response rates and fail for the majority of treated patients. This exposes them to ineffective therapies and unnecessary toxicity.
We believe this can and must change.
Notable’s predictive technology platform can identify — from a blood sample taken before treatment — whether a patient will positively respond to a given treatment.
This enables Notable and its mission-driven team across therapeutics, diagnostics and engineering to focus its clinical development programs solely on responding patients and achieve predictive medicines precisely for them.
Patients will finally get the answer that matters most.